AstraZeneca in Egypt


Welcome to AstraZeneca Egypt

AstraZeneca is a global, science-led pharmaceutical company driven by innovative science and entrepreneurial culture inspired by our purpose and values, we are transforming the future of healthcare by unlocking the power of what science can do- for people, society and the planet.

AstraZeneca Egypt has a solid presence in the Egyptian pharmaceutical market since 1968 and is engaged in the manufacture and supply of medicines that aim to make a real difference to the lives of Egyptians.


650+

employees

Around 95M

Patients served in the past 2 years

Since 1968

Present in the Egyptian pharmaceutical market

Sustainable Headquarters in New Cairo

Gold “LEED” certified building in an eco-friendly area

3 Sales offices

are present in Mansoura, Alexandria & Assiut

Local manufacturing site

located at 6th October city



Our Values and Behaviours

Our values determine how we work together and the behaviours that drive our success. They guide our decision making, define our beliefs and help foster a strong culture at AstraZeneca.




Our Therapy Areas

Unlocking the power of what science can do 




Our Commitment to Patients

Our longstanding commitment to patients has led us to reimagine our patient-focused ways of working, as we embed it across every aspect of our company to deliver the healthcare experience and outcomes people care about most so they can enjoy fulfilling lives.


Our Partnerships and Projects in Egypt








Our Sustainability Approach

Our future depends on healthy people, a healthy society and a healthy planet. We believe that these elements are interconnected, and that together we must build a sustainable future.

As a global business, we are playing our part in tackling the biggest challenges of our time, from climate change to access to healthcare and disease prevention. We are harnessing the power of science and innovation and our global reach to make a positive impact on society, healthcare systems, and the environment. This starts with us, but matters to everyone, everywhere.


Our approach to sustainability has three interdependent and cooperative priorities :





Patient Affordability Program (PAP) pharmacy network expansion

AstraZeneca Egypt hereby invites eligible retail and hospital pharmacies across the Arab Republic of Egypt to submit an expression of interest for consideration as part of its proposed Patient Affordability Program (PAP) pharmacy network.

This proposed network expansion aims to support access to eligible medicines under patient affordability programs, while maintaining continuity of the existing PAP network and patient support services. The initiative is intended to enhance geographic coverage, diversify dispensing channels, and facilitate timely access across Egyptian governorates.

Pharmacies selected for further consideration shall be required to meet AstraZeneca’s applicable operational, quality, and compliance standards, in addition to relevant regulatory requirements.

Important Notice

This announcement is issued for information and response collection purposes only and shall not be construed as an offer to contract or as creating any legal obligation on AstraZeneca Egypt.

Submission of an expression of interest does not guarantee selection.

AstraZeneca Egypt reserves the right to accept, reject, amend, withdraw, or further discuss any response, in accordance with applicable business, operational, quality, regulatory, and compliance requirements.

Submission Period

The submission period will open on 8 SEP 2026 and close in 20 SEP 2026. Submissions received after the closing date will not be considered.

Required Documents

  1. Valid and active pharmacy license
  2. Valid commercial registration and tax card

Required Capabilities

Applicants are expected to demonstrate the following capabilities:

  • Adequate storage and handling conditions
  • Trained and qualified pharmacists
  • Secure documentation and record-keeping systems
  • Ability to support third-party audits
  • Compliance with Egyptian Drug Authority regulations

Expression of Interest

Eligible pharmacies wishing to be considered are invited to submit the required documents and application details through the designated submission channel.

Applied Pharmacies to send the required documents along with the application details to pappharmaciesnetworkexpansion@astrazeneca.com application:

Pharmacy/Hospital Name Name: __________

Is this a chain pharmacy? Yes ☐ No ☐ If yes, Chain Name:__________

Pharmacy/Hospital Address: Governorate:__________ City/Area:__________

Street/Branch Address: ____________________



Egypt Sustainability Green Strategy towards Decarbonization of
Healthcare Post-COP27 and Beyond



External Awards Recognitions


AstraZeneca Egypt

Response during COVID-19 pandemic

AstraZeneca, played a pivotal role in the fight against the COVID-19 pandemic, demonstrating its commitment to scientific innovation and societal well-being. The company's unwavering support during this unprecedented crisis manifested in several crucial initiatives. AstraZeneca's most significant contribution was the development of the Oxford-AstraZeneca COVID-19 vaccine, a highly effective and widely accessible vaccine that played a critical role in curbing the spread of the virus and saving countless lives. The company's commitment to equitable access ensured that the vaccine was available to low- and middle-income countries, bridging the global vaccine divide. Beyond vaccine development, AstraZeneca extended its support to healthcare workers, communities, and governments worldwide. The company donated millions of face masks to protect frontline healthcare workers, supported national testing efforts, and actively participated in clinical trials to investigate potential treatments for the virus.

Join AstraZeneca

and help us deliver life-changing medicines

Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.


Patient Safety

In order to monitor the safety of AstraZeneca products, we encourage reporting any side effects experienced while taking an AstraZeneca product to the AstraZeneca Patient Safety Centre:

Phone: +20 2 25980205
Fax: +20 2 5890225
Email: Patient.SafetyEgypt@astrazeneca.com

https://www.contactazmedical.astrazeneca.com

 



Find Us

Location address: Bureau 58 Business Park,
5th settlement,
New Cairo,
Egypt

Phone: +20 2 2598 0222

Location on maps: AstraZeneca Egypt Office

EG-9188